Biomarkers in Neuroimaging


Track 23 : Biomarkers in Neuroimaging



Neuroimaging has helped to elucidate that substance-use disorders are related to changes in brain structure, function, and neurochemistryNeuroimaging studies have improved our understanding of the neural correlates of addiction and the way these relate to addictive behaviour. Never the less, the potential impact of neuroimaging on treatment and development for addictions has yet to be fully realized. Despite steady advances, cure for the diseases are often not fully effective, and addiction continues to be a serious public health problem. Neuroimaging has contributed to our appreciation of the complexity of addiction, highlighting the necessity for measurable indices, or biomarkers, of addiction to enhance treatment outcomes. A “biomarker” generally refers to a measurable indicator of normal or abnormal biological processes or response to treatment. In substance-abuse research, biomarkers are needed to clarify how or why a treatment has an impact, on whom and under what circumstances.



 



Recent advances in neuroimaging are affording greater opportunities to spot brain biomarkers which may be wont to improve outcomes of treatment for substance-use disorders. Neuroimaging can be a very critical tool in biomarker development because it relates neural circuits to both molecular mechanisms and behaviour or clinical variations. especially , neuroimaging studies are central to an emerging attempt to spot cross-diagnostic processes in substance-use and related disorders supported both behaviour and neural circuits . during this work, alterations in brain activation patterns related to dimensions of functioning in individuals with addictions could also be considered to represent abnormal processing associated with addictive behaviour.  As disorder heterogeneity pose significant challenges for delivering effective treatment, considering addictions in terms of dimensions of functioning may help to elucidate factors relevant to treatment response and cause more specific, simpler treatments. This paper reviews neuroimaging research seeking to spot potential biomarkers of treatment response from several dimensions of functioning relevant to addictionimpulsivity, and cognitive control.



 


    Related Conference of Biomarkers in Neuroimaging

    February 03-04, 2025

    37th World Conference on Neurology

    London, UK
    February 17-18, 2025

    5th International Conference on Child Neurology

    Aix-en-Provence, France
    February 20-21, 2025

    6th International Conference on Neurologists

    Amsterdam, Netherlands
    February 24-25, 2025

    4th International Conference onAlzheimer and Dementia

    Madrid, Spain
    February 27-28, 2025

    7th World Depression Congress

    Paris, France
    March 10-11, 2025

    8th World Conference on Neuroscience

    Paris, France
    March 13-14, 2025

    7th World Conference on Neuroscience

    Prague, Czech Republic
    March 24-25, 2025

    38th European Neurology Congress 2025

    London, UK
    April 24-25, 2025

    6th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    April 29-30, 2025

    11th International Conference on Epilepsy & Treatment

    Barcelona, Spain
    May 12-13, 2025

    39th European Neurology Congress

    London, UK
    July 17-18, 2025

    31st Annual Summit on Neuroscience & Neurological Disorders

    Amsterdam, Netherlands
    July 23-24, 2025

    15th Global Alzheimers Summit

    Paris, France
    July 28-29, 2025

    35th World Congress on Neurology and Neuroscience

    Paris, France
    August 25-26, 2025

    20th Annual Congress on Neuroscience

    Aix-en-Provence, France
    September 25-26, 2025

    12th Annual congress on Stroke and Neurological Disorders

    Zurich, Switzerland
    October 20-21, 2025

    7th World Brain Congress

    Osaka, Japan
    October 29-30, 2025

    5th Annual Dementia Congress

    Amsterdam, Netherlands
    November 13-14, 2025

    38th International Conference on Neuroscience and Neurochemistry

    Aix-en-Provence, France

    Biomarkers in Neuroimaging Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in